ECSP993116A - Procedimiento para administrar peptidos insulinotropicos - Google Patents
Procedimiento para administrar peptidos insulinotropicosInfo
- Publication number
- ECSP993116A ECSP993116A ECSP993116A ECSP993116A EC SP993116 A ECSP993116 A EC SP993116A EC SP993116 A ECSP993116 A EC SP993116A EC SP993116 A ECSP993116 A EC SP993116A
- Authority
- EC
- Ecuador
- Prior art keywords
- administering
- procedure
- insulinotropic peptides
- peptide
- molecules
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000002473 insulinotropic effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 abstract 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 2
- 102100040918 Pro-glucagon Human genes 0.000 abstract 2
- 102000051325 Glucagon Human genes 0.000 abstract 1
- 108060003199 Glucagon Proteins 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 abstract 1
- 229960004666 glucagon Drugs 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención reivindicada se refiere a un procedimiento para administrar por inhalación moléculas del péptido 1 similar al glucagón, a un procedimiento para tratar la diabetes administarndo por inhalación moléculas del péptido 1 similar al glucagón y a un procedimiento para tratar la hiperglucemia administrando por inhalación moléculas del péptido 1 similar al glucagón.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993116 ECSP993116A (es) | 1999-08-27 | 1999-08-27 | Procedimiento para administrar peptidos insulinotropicos |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993116 ECSP993116A (es) | 1999-08-27 | 1999-08-27 | Procedimiento para administrar peptidos insulinotropicos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993116A true ECSP993116A (es) | 1999-11-29 |
Family
ID=42044104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993116 ECSP993116A (es) | 1999-08-27 | 1999-08-27 | Procedimiento para administrar peptidos insulinotropicos |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993116A (es) |
-
1999
- 1999-08-27 EC ECSP993116 patent/ECSP993116A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022368A1 (es) | Procedimiento para administrar peptidos insulinotropicos | |
| IL176541A0 (en) | Intranasal administration of glucose-regulating peptides | |
| WO2006024275A3 (de) | Erfindung betreffend glp-1 und exendin | |
| ATE251642T1 (de) | Biologisch aktive fragmente des glucagon ähnlichen, insulinotropen peptides | |
| EA200000747A1 (ru) | СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА | |
| WO2003011892A3 (en) | Glp-1 exendin-4 peptide analogs and uses thereof | |
| DK1171465T3 (da) | Analoger til gastroinhibitorisk peptid og deres anvendelse til behandling af diabetes | |
| WO2006121860A3 (en) | Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use | |
| YU31004A (sh) | Mimetici humanog glukagonu sličnog peptida-1 i njihova upotreba u lečenju dijabetesa i srodnih stanja | |
| DK1523325T3 (da) | Fremgangsmåder og sammensætninger til behandling af polycystisk ovariesyndrom | |
| IL208184A0 (en) | Glp-1, and methods for treating diabetes | |
| MX2022009149A (es) | Compuestos coagonistas de gip/glp1. | |
| NZ527241A (en) | Analogues of GLP-1 | |
| DE68929217D1 (en) | Insulinotropes hormon | |
| SE9802080D0 (sv) | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein | |
| WO2004094461A3 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
| PH12020551659A1 (en) | Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof | |
| IL146868A0 (en) | A pharmaceutical composition containing an igf-i/igfbp-3 complex | |
| ECSP993116A (es) | Procedimiento para administrar peptidos insulinotropicos | |
| ATE346601T1 (de) | Verwendung von antidiabetika zur herstellung eines vernarbungsfördernden arzneimittels | |
| TW200509960A (en) | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |